A novel method for determining the inhibitory potential of anti-HIV drugs

Lin Shen, S. Alireza Rabi, Robert F. Siliciano

Research output: Contribution to journalArticle

Abstract

In the absence of cure, most HIV-1-infected individuals will require lifelong treatment. It is therefore essential to optimize highly active antiretroviral therapy. Recent research has shown that the slope parameter or Hill coefficient, which describes the steepness of a dose-response curve, is a critical missing dimension in the evaluation of the activity of antiviral drugs. Based on this finding, instantaneous inhibitory potential (IIP) has been derived as a new measure of antiviral drug activity. IIP incorporates the slope parameter and thus is a more accurate pharmacodynamic measure of antiviral activity than current measures such as IC50 and inhibitory quotient. Determining how to use IIP to predict the in vivo efficacy of anti-HIV-1 drugs is nevertheless important. This article discusses recent advances in in vitro measures of antiviral activity and the therapeutic implications of the dose-response curve slope and IIP.

Original languageEnglish (US)
Pages (from-to)610-616
Number of pages7
JournalTrends in Pharmacological Sciences
Volume30
Issue number12
DOIs
StatePublished - Dec 1 2009

    Fingerprint

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this